表纸
市场调查报告书

全球基因咨询市场(2019-2030)

Global Genetic Counseling Market: Focus on Counseling Approach, Key Players Type, Counseling Channel, Type of Service, Application, Target Population, Level of Service, Country Data and Competitive Landscape - Analysis and Forecast, 2019-2030

出版商 BIS Research Inc. 商品编码 949761
出版日期 内容资讯 英文 195 Pages
商品交期: 最快1-2个工作天内
价格
全球基因咨询市场(2019-2030) Global Genetic Counseling Market: Focus on Counseling Approach, Key Players Type, Counseling Channel, Type of Service, Application, Target Population, Level of Service, Country Data and Competitive Landscape - Analysis and Forecast, 2019-2030
出版日期: 2020年07月10日内容资讯: 英文 195 Pages
简介

全球遗传咨询市场预计到2030年将增长到40.793亿美元。最初,遗传咨询支持服务主要用于遗传疾病的风险评估,产前/孕前咨询以及对儿童的风险护理,但是随著新业务的进入,药物基因组学/诊断咨询也是当前诊断和治疗的主要部分。政府意识增强,对遗传状况的意识增强和遗传咨询师数量增加等因素正在推动市场的增长。

本报告调查了全球遗传咨询市场,并概述了市场定义,对影响市场增长的各种因素的分析,相关法律法规,市场规模趋势和预测,咨询方法,服务类型以及它按应用类别,地区/主要国家,竞争环境,主要公司的概况等各种类别汇总了细分。

执行摘要

第1章产品定义

第2章市场范围

第3章调查方法

第4章市场概述

  • 参与者,情况,最新趋势
  • 遗传咨询师统计

第5章行业分析

  • 与遗传咨询有关的规定:积极组织
  • 指南和规定
    • 美国
    • 欧洲
    • 澳大利亚
  • 兑换场景
    • 美国
    • 欧洲
    • 澳大利亚

第6章市场动态

  • 增长动力
  • 生长抑制剂
  • 市场机会

第7章竞争情况

  • 主要战略与发展
  • 服务方案
  • 市场份额分析
  • 增长份额分析:市场机会映射

第8章咨询方法的市场分析和预测

  • 综合遗传咨询
  • 自由裁量遗传咨询
  • 独立遗传咨询

第9章市场分析和预测:按公司的业务模型

  • 核心遗传咨询公司
  • D2C检查公司
  • 临床基因检测公司

第10章按渠道进行市场分析和预测

  • 提供者
  • 自我介绍类型

第11章按服务类型进行的市场分析和预测

  • 风险评估
  • 药物基因组学
  • 其他

第12章按应用进行市场分析和预测

  • 主动风险评估
  • ITT(意向治疗)患者GC
  • 产前/产前检查
  • 儿科护理
  • 其他

第13章按人群划分的市场分析和预测

  • 一般
  • 患者

第14章按服务水平进行市场分析和预测

  • 咨询前的支持
  • 咨询后的支持

第15章按地区和主要国家进行的市场分析和预测

  • 概述
  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区

第16章公司简介

  • Quest Diagnostics Incorporated
  • Invitae Corporation
  • Laboratory Corporation of America
  • Arup Laboratories
  • Genome Medical
  • MyOncoPath
  • GeneMatters
  • EasyDNA
  • AT-GC
  • Biron Health Group
  • Metis Genetics
  • GeneScreen
  • GeneHealth UK
  • Veritas Genetics
  • InformedDNA
  • Ancestry
  • Color Genomics
  • GeneDX (an Opko Health Company)
  • GenPath Diagnostics (an Opko Health Company)
目录
Product Code: BHP0939SA

"Global Genetic Counseling Market to Reach $4,079.3 Million by 2030."

Market Segmentation

  • By Key Players Business Model: Core Genetic Counseling Companies, Direct-to-Consumer Genetic Testing Companies, and Clinical Genetic Testing Companies
  • By Counseling Approach: Integrated, Independent, and Discretionary Genetic Counseling
  • By Level of Service: Pre- and Post-Genetic Counseling Services
  • By Target Population: General Population and Intent-to-Treat Patient Population
  • By Type of Service: Risk Assessment Counseling and Pharmacogenomic Counseling
  • By Type of Application: Prenatal/Preconception Care, Pediatric Care, Indication Risk Assessment, and Genetic Counseling for Intent-to-Treat Patients
  • By Type of Counseling Channel: Providers and Self-Referred Individuals
  • By Region: North America, Europe, Asia Pacific, and Rest-of-the-World

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, Romania, Netherlands, Norway, Rest-of-Europe
  • Asia-Pacific - China, Japan, India, Taiwan, New Zealand, South Korea, Australia, Rest-of-APAC
  • Rest-of-the-World

Growth Drivers

  • Rapid Rise in Number of Genetic Counselors' Workforce
  • Increasing Adoption of Inorganic Growth Strategies in the Market
  • Rising Demand of Prenatal and Preconception Genetic Support Services in Major Geographies

Market Challenges

  • Limited Reimbursement Among Major Insurance Providers
  • Lack of Genetic Counselors

Market Opportunities

  • Healthcare Costs Mitigation
  • Expected Implementation of H.R. 3235 Bill in the U.S.
  • Entry of New Genetic Counseling Platforms to Maximize Counselors' Productivity

Key Genetic Counseling Companies Profiled

InformedDNA, Integrated Genetics (Laboratory Corporation of America), Quest Diagnostics Incorporated, Genome Medical, ARUP Laboratories, Invitae Corporation, GeneMatters, and MyOncoPath.

Key Questions Answered in this Report:

  • What is genetic counseling? How different settings for genetic counseling has evolved over the centuries?
  • What are the major market drivers, challenges, and opportunities in the global genetic counseling market?
  • What was the global genetic counseling market size in terms of revenue in 2019? How is the market expected to evolve in the upcoming years? What is the expected market size in 2030?
  • How is each segment of the global genetic counseling market expected to grow during the forecast period between 2020 to 2030, and what revenue is expected to be generated by each of the segments by the end of 2030?
  • What are the developmental strategies implemented by the key players to sustain in the competitive market?
  • What is the growth potential of the global genetic counseling in several countries globally?
  • Which service segment among the four (proactive indication risk assessment, prenatal/preconception, pediatric, or pharmacogenomic) are offered by key players such as Integrated Genetics (Laboratory Corporation of America), InformedDNA, Genome Medical, Quest Diagnostics Incorporated, MyOncoPath, among others?
  • Which genetic counseling approach was leading the market in 2019 and is expected to dominate the market in 2030, and why?
  • Which application type is leading the market in 2019 and is expected to dominate the market in 2030 and why?
  • Which region dominated the global genetic counseling market in 2019, and what are the expected trends from each of the regions in the forecast period 2020-2030?

Market Overview

Genetic Counseling is a communication process that intends to assist at-risk or affected individuals and families in understanding the disease risks, mode of transmission, and natural history of a genetic disorder. The approach also facilitates informed consent for genetic tests when required, in settings such as family planning and risk management services.

Traditionally, the genetic counseling support services had mainly been offered for settings such as indication risk assessment and other segments of prenatal/preconception, and pediatric risk care. However, with the advent of new players in the genetic counseling market, pharmacogenomic services and diagnostic counseling services have become an eminent part of current diagnostic and treatment practices. Several players, such as Genome Medical and MyOncoPath, are currently offering these services in the market. The entry of new players in the market, coupled up with increased innovation pertaining to cost mitigation and resource output maximization had transformed the market currently.

The existing market of genetic counseling is favored by multiple factors, which include rising government initiatives, coupled up with general population's growing awareness pertaining to genetic conditions. Additionally, the increasing number of genetic counselors in both industry and hospital settings is also one of the key driving factors for genetic counseling market.

Within the research report, the market is segmented on the basis of key players business model (core genetic counseling company, clinical genetic testing company, and direct-to-consumer testing company), genetic counseling approach (integrated counseling, discretionary counseling, and independent counseling services), level of counseling (pre- and post-counseling support), target population (general population and patients), type of service (risk assessment counseling and pharmacogenomic counseling), application( prenatal/preconception care, pediatric care, indication risk assessment, and genetic counseling for intent-to-treat patients), counseling channel (providers and self-referred individuals) and region (North America, Europe, Asia Pacific and Rest-of-the-World). This segmentation highlights value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide a 360-coverage of the domain.

Competitive Landscape

Major players, including Genome Medical, GeneMatters, Fulgent Genetics, and InformedDNA, among others, led the number of synergistic developments (partnerships and alliances) witnessed by the market. On the basis of region, North America is expected to retain a leading position throughout the forecast period 2020-2030, followed by Europe. This is a result of the presence of leading industry players in this region, coupled up with a rising number of genetic conditions.

Table of Contents

Executive Summary

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Market Scope

  • 2.1 Scope of Work
  • 2.2 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Global Genetic Counseling Market: Research Methodology
  • 3.2 Data Sources
  • 3.3 Secondary Data Sources
  • 3.4 Market Estimation Model
  • 3.5 Criteria for Company Profiling

4 Market Overview

  • 4.1 Industry Participants, Landscape, and Recent Trends
  • 4.2 Genetic Counselors Statistics

5 Industry Insights

  • 5.1 Active Organizations for Genetic Counseling Regulation
  • 5.2 Guidelines and Regulation for Genetic Counseling
    • 5.2.1 U.S.
      • 5.2.1.1 Guidelines
      • 5.2.1.2 Regulation
    • 5.2.2 Europe
      • 5.2.2.1 Guidelines
      • 5.2.2.2 Regulation
    • 5.2.3 Australia
      • 5.2.3.1 Guidelines
      • 5.2.3.2 Regulation
  • 5.3 Reimbursement Scenario
    • 5.3.1 U.S.
    • 5.3.2 Europe
    • 5.3.3 Australia

6 Market Dynamics

  • 6.1 Market Drivers
    • 6.1.1 Rapid Rise in Number of Genetic Counselors Workforce
    • 6.1.2 Increasing Adoption of Inorganic Growth Strategies in the Market
    • 6.1.3 Rising Demand of Prenatal and Preconception Genetic Support Services in Major Geographies
  • 6.2 Restraints
    • 6.2.1 Limited Reimbursement Among Major Insurance Providers
    • 6.2.2 Lack of Genetic Counselors
  • 6.3 Market Opportunities
    • 6.3.1 Healthcare Costs Mitigation
    • 6.3.2 Expected Implementation of H.R. 3235 Bill in the U.S.
    • 6.3.3 Entry of New Genetic Counseling Platforms to Maximize Counselors' Productivity

7 Competitive Landscape

  • 7.1 Key Strategies and Developments
    • 7.1.1 Synergistic Activities
    • 7.1.2 Regulatory Accreditations
    • 7.1.3 Service Launches
    • 7.1.4 Acquisitions, Mergers and Spin-offs
  • 7.2 Service Scenario
    • 7.2.1 Funding Scenario
  • 7.3 Market Share Analysis
  • 7.4 Growth-Share Analysis (Opportunity Mapping)
    • 7.4.1 By Company
    • 7.4.2 By Target Population
    • 7.4.3 By Counseling Approach
    • 7.4.4 By Application

8 Global Genetic Counseling Market (by Counseling Approach)

  • 8.1 Integrated Genetic Counseling
  • 8.2 Discretionary Genetic Counseling
  • 8.3 Independent Genetic Counseling

9 Global Genetic Counseling Market (by Key Players Business Model)

  • 9.1 Core Genetic Counseling Companies
  • 9.2 Direct-to-Consumer Testing Companies
  • 9.3 Clinical Genetic Testing Companies

10 Global Genetic Counseling Market (by Channel)

  • 10.1 Providers
  • 10.2 Self-Referred Individuals

11 Global Genetic Counseling Market (by Type of Service)

  • 11.1 Risk Assessment
  • 11.2 Pharmacogenomics
  • 11.3 Other Genetic Counseling Services

12 Global Genetic Counseling Market (by Application)

  • 12.1 Proactive Risk Assessment
  • 12.2 GC For Intent-to-Treat Patients (ITT)
  • 12.3 Prenatal and Preconception Care
  • 12.4 Pediatric Care
  • 12.5 Other Genetic Counseling Applications

13 Global Genetic Counseling Market (by Target Population Segment)

  • 13.1 General Population
  • 13.2 Patient Population

14 Global Genetic Counseling Market (by Level of Service)

  • 14.1 Pre-counseling Support
  • 14.2 Post Counseling Support

15 Global Genetic Counseling Market (by Region)

  • 15.1 Overview
  • 15.2 North America
    • 15.2.1 U.S.
    • 15.2.2 Canada
  • 15.3 Europe
    • 15.3.1 Germany
    • 15.3.2 U.K.
    • 15.3.3 France
    • 15.3.4 Italy
    • 15.3.5 Spain
    • 15.3.6 Romania
    • 15.3.7 Netherlands
    • 15.3.8 Norway
    • 15.3.9 Rest-of-Europe
  • 15.4 Asia-Pacific
    • 15.4.1 China
    • 15.4.2 Japan
    • 15.4.3 India
    • 15.4.4 Taiwan
    • 15.4.5 New Zealand
    • 15.4.6 South Korea
    • 15.4.7 Australia
    • 15.4.8 Rest-of-APAC
  • 15.5 Rest-of-the-World

16 Company Profiles

  • 16.1 Overview
  • 16.2 Quest Diagnostics Incorporated
    • 16.2.1 Company Overview
    • 16.2.2 Role of Quest Diagnostics Incorporated in the Global Genetic Counseling Market
    • 16.2.3 Financials
    • 16.2.4 SWOT Analysis
  • 16.3 Invitae Corporation
    • 16.3.1 Company Overview
    • 16.3.2 Role of Invitae Corporation, Inc. in the Global Genetic Counseling Market
    • 16.3.3 Financials
    • 16.3.4 SWOT Analysis
  • 16.4 Laboratory Corporation of America
    • 16.4.1 Company Overview
    • 16.4.2 Role of Laboratory Corporation of America Holdings in the Global Genetic Counseling Market
    • 16.4.3 Financials
    • 16.4.4 SWOT Analysis
  • 16.5 Arup Laboratories
    • 16.5.1 Company Overview
    • 16.5.2 Role of ARUP Laboratories in the Global Genetic Counseling Market
    • 16.5.3 SWOT Analysis
  • 16.6 Genome Medical
    • 16.6.1 Company Overview
    • 16.6.2 Role of Genome Medical in the Global Genetic Counseling Market
    • 16.6.3 SWOT Analysis
  • 16.7 MyOncoPath
    • 16.7.1 Company Overview
    • 16.7.2 Role of MyOncoPath in the Genetic Counseling Market
    • 16.7.3 SWOT Analysis
  • 16.8 GeneMatters
    • 16.8.1 Company Overview
    • 16.8.2 Role of GeneMatters in the Genetic Counseling Market
    • 16.8.3 SWOT Analysis
  • 16.9 EasyDNA
    • 16.9.1 Company Overview
    • 16.9.2 Role of EasyDNA in the Global Genetic Counseling Market
    • 16.9.3 SWOT Analysis
  • 16.1 AT-GC
    • 16.10.1 Company Overview
    • 16.10.2 Role of AT-GC in the Global Genetic Counseling Market
    • 16.10.3 SWOT Analysis
  • 16.11 Biron Health Group
    • 16.11.1 Company Overview
    • 16.11.2 Role of Biron Health Group in the Global Genetic Counseling Market
    • 16.11.3 SWOT Analysis
  • 16.12 Metis Genetics
    • 16.12.1 Company Overview
    • 16.12.2 Role of Metis Genetics in the Global Genetic Counseling Market
    • 16.12.3 SWOT Analysis
  • 16.13 GeneScreen
    • 16.13.1 Company Overview
    • 16.13.2 Role of GeneScreen in the Global Genetic Counseling Market
    • 16.13.3 SWOT Analysis
  • 16.14 GeneHealth UK
    • 16.14.1 Company Overview
    • 16.14.2 Role of GeneHealth UK in the Global Genetic Counseling Market
    • 16.14.3 SWOT Analysis
  • 16.15 Veritas Genetics
    • 16.15.1 Company Overview
    • 16.15.2 Role of Veritas Genetics in the Global Genetic Counseling Market
    • 16.15.3 SWOT Analysis
  • 16.16 InformedDNA
    • 16.16.1 Company Overview
    • 16.16.2 Role of InformedDNA in the Global Genetic Counseling Market
    • 16.16.3 SWOT Analysis
  • 16.17 Ancestry
    • 16.17.1 Company Overview
    • 16.17.2 Role of Ancestry in the Global Genetic Counseling Market
    • 16.17.3 SWOT Analysis
  • 16.18 Color Genomics
    • 16.18.1 Company Overview
    • 16.18.2 Role of Color Genomics in the Global Genetic Counseling Market
    • 16.18.3 SWOT Analysis
  • 16.19 GeneDX (an Opko Health Company)
    • 16.19.1 Company Overview
    • 16.19.2 Role of GeneDX in the Global Genetic Counseling Market
    • 16.19.3 SWOT Analysis
  • 16.2 GenPath Diagnostics (an Opko Health Company)
    • 16.20.1 Company Overview
    • 16.20.2 Role of GenPath Diagnostics in the Global Genetic Counseling Market
    • 16.20.3 SWOT Analysis

List of Tables

  • Table 4.1: Global Genetic Counseling Market, by Region, ($Million), 2019-2030
  • Table 4.2: Genetic Counselors Statistics (by Country)
  • Table 5.1: Active Organization for Genetic Counseling
  • Table 5.2: Companies and Relative Coverage Status in the U.S.
  • Table 5.3: Companies and Relative Coverage Status in the Europe
  • Table 5.4: Companies and Relative Coverage Status in the Australia

List of Figures

  • Figure 1: Impact Analysis of Market Drivers and Market Challenges on the Global Genetic Counseling Market
  • Figure 2: Global Genetic Counseling Market (by Key Players' Business Model), $Million, 2019 and 2030
  • Figure 3: Global Genetic Counseling Market (by Counseling Approach), $Million, 2019 and 2030
  • Figure 4: Global Genetic Counseling Market (by Counseling Channel), $Million, 2019 and 2030
  • Figure 5: Global Genetic Counseling Market (by Type of Service), $Million, 2019 and 2030
  • Figure 6: Global Genetic Counseling Market (by Application), $Million, 2019 and 2030
  • Figure 7: Global Genetic Counseling Market (by Target Population), $Million, 2019 and 2030
  • Figure 8: Global Genetic Counseling Market (by Level of Service), $Million, 2019 and 2030
  • Figure 9: Global Genetic Counseling Market (by Region), $Million, 2019
  • Figure 2.1: Global Genetic Counseling Market Segmentation
  • Figure 3.1: Global Genetic Counseling Market Research Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: Global Genetic Counseling Market, 2019-2030 ($Million)
  • Figure 4.2: Genetic Counseling Companies as Per Business Model
  • Figure 4.3: Approaches for Genetic Counseling
  • Figure 4.4: Key Strategies Adopted by Market Players
  • Figure 4.5: Genetic Counselors Statistics and Active Hospital Networks in North America
  • Figure 4.6: Genetic Counselors Statistics and Active Hospital Networks in Europe, APAC, and Rest-of-the-World (RoW)
  • Figure 5.1: Genetic Counseling Guidelines Adopted in the U.S.
  • Figure 5.2: Licensure Status for Genetic Counselors in the U.S.
  • Figure 5.3: HGSA Genetic Counseling Guidelines
  • Figure 5.4: Genetic Counseling Regulatory Authorities in Australia
  • Figure 6.1: Market Dynamics of Global Genetic Counseling Market
  • Figure 6.2: Number of Genetic Counselors in the U.S., 2010-2018
  • Figure 6.3: Synergistic Activities, 2017-2019
  • Figure 7.1: Share of Key Developments and Strategies, January 2017-December 2019
  • Figure 7.2: Synergistic Activities Share (by Company), January 2017-December 2019
  • Figure 7.3: Accreditations Share (by Company), January 2017-December 2019
  • Figure 7.4: Service Launches Share (by Company), January 2017-December 2019
  • Figure 7.5: Acquisitions, Mergers and Spin-offs Share (by Company), January 2017-December 2019
  • Figure 7.6: Genetic Counseling Funding Scenario
  • Figure 7.7: Market Share Analysis for Global Genetic Counseling Market, 2019
  • Figure 7.8: Growth-Share Matrix for Global Genetic Counseling Market (by Company), 2019
  • Figure 7.9: Growth-Share Matrix for Global Genetic Counseling Market (by Target Population), 2019-2030
  • Figure 7.10: Growth-Share Matrix for Global Genetic Counseling Market (by Counseling Approach), 2019-2030
  • Figure 7.11: Growth-Share Matrix for Global Genetic Counseling Market (by Application), 2019-2030
  • Figure 8.1: Global Genetic Counseling Market (by Counseling Approach), 2019 vs. 2030
  • Figure 8.2: Integrated Genetic Counseling Market, $Million, 2019-2030
  • Figure 8.3: Discretionary Genetic Counseling Market, $Million, 2019-2030
  • Figure 8.4: Independent Genetic Counseling Market, $Million, 2019-2030
  • Figure 9.1: Global Genetic Counseling Market (by Key Players' Business Model), 2019 vs 2030
  • Figure 9.2: Genetic Counseling Market by Core Genetic Counseling Segment, $Million, 2019-2030
  • Figure 9.3: Genetic Counseling Market by Direct-to-Consumer Testing Segment, $Million, 2019-2030
  • Figure 9.4: Genetic Counseling Market (by Clinical Genetic Testing Segment), $Million, 2019-2030
  • Figure 10.1: Global Genetic Counseling Market (by Counseling Channel), 2019 vs. 2030
  • Figure 10.2: Genetic Counseling Market by Provider Segment, $Million, 2019-2030
  • Figure 10.3: Genetic Counseling Market by Self-Referred Individuals Segment, $Million, 2019-2030
  • Figure 11.1: Global Genetic Counseling Market (by Type of Service), 2019 vs. 2030
  • Figure 11.2: Genetic Counseling Market by Risk Assessment Segment, $Million, 2019-2030
  • Figure 11.3: Genetic Counseling Market by Pharmacogenomics Segment, $Million, 2019-2030
  • Figure 11.4: Genetic Counseling Market by Other Genetic Counseling Services Segment, $Million, 2019-2030
  • Figure 12.1: Global Genetic Counseling Market (by Application), 2019 vs. 2030
  • Figure 12.2: Indication Risk Assessment Market, $Million, 2019-2030
  • Figure 12.3: Intent-to-treat patients Intent-to-treat Patients Market, $Million, 2019-2030
  • Figure 12.4: Prenatal/Preconception Care Market, $Million, 2019-2030
  • Figure 12.5: Pediatric Care Market, $Million, 2019-2030
  • Figure 12.6: Other GC Applications Market, $Million, 2019-2030
  • Figure 13.1: Global Genetic Counseling Market (by Target Population), 2019 vs. 2030
  • Figure 13.2: Global Genetic Counseling Market by General Population Segment, $Million, 2019-2030
  • Figure 13.3: Global Genetic Counseling Market by Patient Population Segment, $Million, 2019-2030
  • Figure 14.1: Global Genetic Counseling Market (by Level of Service), 2019 vs 2030
  • Figure 14.2: Global Genetic Counseling Market by Pre-counseling Support, $Million, 2019-2030
  • Figure 14.3: Global Genetic Counseling Market by Post-counseling Support, $Million, 2019-2030
  • Figure 15.1: Global Genetic Counseling Market (by Region), $Million, 2019 vs. 2030
  • Figure 15.2: North America: Market Dynamics
  • Figure 15.3: North America Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.4: North America Genetic Counseling Market (by Country), $Million, 2019 vs 2030
  • Figure 15.5: U.S. Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.6: Key Drivers of the U.S. Genetic Counseling Market
  • Figure 15.7: Canada Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.8: Europe: Market Dynamics
  • Figure 15.9: Europe Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.10: Europe Genetic Counseling Market (by Country), $Million, 2019 vs. 2030
  • Figure 15.11: Germany Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.12: U.K. Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.13: France Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.14: Italy Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.15: Spain Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.16: Romania Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.17: Netherlands Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.18: Norway Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.19: Rest-of-Europe Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.20: Asia-Pacific: Market Dynamics
  • Figure 15.21: Asia-Pacific Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.22: Asia-Pacific Genetic Counseling Market (by Country), $Million, 2019 vs. 2030
  • Figure 15.23: China Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.24: Japan Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.25: India Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.26: Taiwan Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.27: New Zealand Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.28: South Korea Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.29: Australia Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.30: Rest-of-APAC Genetic Counseling Market, $Million, 2019-2030
  • Figure 15.31: Rest-of-the-World: Market Dynamics
  • Figure 15.32: Rest-of-the-World Genetic Counseling Market, $Million, 2019-2030
  • Figure 16.1: Total Number of Companies Profiled
  • Figure 16.2: Quest Diagnostics Incorporated: Portfolio
  • Figure 16.3: Quest Diagnostics Incorporated: Overall Financials, 2017-2019
  • Figure 16.4: Quest Diagnostics Incorporated: Revenue (by Business Segment), 2017-2019
  • Figure 16.5: Quest Diagnostics Incorporated: SWOT Analysis
  • Figure 16.6: Invitae Corporation: Portfolio
  • Figure 16.7: Invitae Corporation: Overall Financials, 2017-2019
  • Figure 16.8: Invitae Corporation: Revenue (by Segment), 2017-2019
  • Figure 16.9: Invitae Corporation: Revenue (by Geography), 2017-2019
  • Figure 16.10: Invitae Corporation: R&D Expenditure, 2017-2019
  • Figure 16.11: Invitae Corporation: SWOT Analysis
  • Figure 16.12: Laboratory Corporation of America Holdings: Service Portfolio
  • Figure 16.13: Laboratory Corporation of America Holdings: Overall Financials, 2017-2019
  • Figure 16.14: Laboratory Corporation of America Holdings: Revenue (by Segment), 2017-2019
  • Figure 16.15: Laboratory Corporation of America Holdings: Revenue (by Region), 2019
  • Figure 16.16: Laboratory Corporation of America Holdings: SWOT Analysis
  • Figure 16.17: ARUP Laboratories: SWOT Analysis
  • Figure 16.18: Genome Medical: SWOT Analysis
  • Figure 16.19: MyOncoPath: SWOT Analysis
  • Figure 16.20: GeneMatters: SWOT Analysis
  • Figure 16.21: EasyDNA: SWOT Analysis
  • Figure 16.22: AT-GC: SWOT Analysis
  • Figure 16.23: Biron Health Group: SWOT Analysis
  • Figure 16.24: Metis Genetics: SWOT Analysis
  • Figure 16.25: Gene Screen: SWOT Analysis
  • Figure 16.26: GeneHealth UK: SWOT Analysis
  • Figure 16.27: Veritas Genetics: SWOT Analysis
  • Figure 16.28: Informed DNA: SWOT Analysis
  • Figure 16.29: Ancestry: SWOT Analysis
  • Figure 16.30: Color Genomics: SWOT Analysis
  • Figure 16.31: GeneDX: SWOT Analysis
  • Figure 16.32: GenPath Diagnostics: SWOT Analysis